Back to Search
Start Over
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
- Source :
- Blood Cancer Journal, Blood Cancer Journal, Vol 10, Iss 6, Pp 1-6 (2020)
- Publication Year :
- 2020
-
Abstract
- Not available.
- Subjects :
- Adult
Male
medicine.medical_specialty
Antineoplastic Agents
Arterial Occlusive Diseases
Gastroenterology
lcsh:RC254-282
chronic myeloid leukemia, TKI, ponatinib, arterial occlusive events
Article
chemistry.chemical_compound
Young Adult
Myeloproliferative disease
High-density lipoprotein
Low low-density lipoprotein, LDL, cholesterol, triglycerides, arterial occlusive events, chronic myeloid leukemia, ponatinib, CML, Campus
chronic myeloid leukemia
Internal medicine
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medicine
Humans
ponatinib
Artery occlusion
arterial occlusive events
Triglycerides
Aged
Aged, 80 and over
business.industry
Cholesterol
Ponatinib
Imidazoles
Myeloid leukemia
Hematology
Middle Aged
Protective Factors
medicine.disease
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
TKI
Lipoproteins, LDL
Pyridazines
Leukemia
Oncology
chemistry
Risk factors
Low-density lipoprotein
Female
business
Dyslipidemia
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Blood Cancer Journal, Blood Cancer Journal, Vol 10, Iss 6, Pp 1-6 (2020)
- Accession number :
- edsair.doi.dedup.....0b33cdd0cc3889d34a7c0ee3be302fd2